# Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

> **NCT00755274** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 32 (actual)

## Conditions studied

- Influenza
- Orthomyxoviridae Infections

## Interventions

- **BIOLOGICAL:** Influenza Virus Vaccine No Preservative: Pediatric Dose
- **BIOLOGICAL:** Influenza Virus Vaccine No Preservative: Pediatric Dose

## Key facts

- **NCT ID:** NCT00755274
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755274, "Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00755274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*